Dendritic Cell-Immunotherapy

· University Hospital Antwerp

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Dendritic Cell-Immunotherapy, covering 2017-10-24 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients [Phase 1, Phase 2]